+254.2%
MRNA vs LSCC
+118.1%
+136.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | LSCC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | +10.4% | -11.2% | -4.1% |
| 7D | -3.8% | +14.5% | -18.2% | -7.9% |
| 30D | +16.4% | -0.1% | +16.4% | +15.7% |
| 3M | +310.6% | -2.7% | +313.2% | +305.9% |
| 6M | +370.3% | -4.8% | +375.1% | +356.2% |
| YTD | +743.3% | +66.9% | +676.5% | +522.7% |
| 1Y | +841.7% | +85.8% | +755.8% | +563.4% |
| All | +254.2% | +118.1% | +136.1% | +105.3% |
Cumulative growth
Daily Returns
Daily percentage return beside LSCC.
Daily Out/Under-Performance
Portfolio return minus LSCC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LSCC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded LSCC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling